Back to video list Back to Home Can you comment on cardiovascular safety of CGRP pathway monoclonal antibody? You may also like Depression Schizophrenia Congress highlights Article Highlights from ECNP 2022 – Day 3 – October 17th Anxiety Article Optimising clinical management in panic disorder Schizophrenia Article Schizophrenia: more same than different to neurodevelopmental disorders? Depression Interview Article “MENTAL HEALTH IN TIMES OF COVID-19”: WORK FROM HOME, FINANCIAL WORRIES, FATIGUE. HOW TO COPE WITH STRESS CREATED BY COVID-19